Go Pro

Avantor (AVTR) Competitors

Avantor logo
$10.40 -0.12 (-1.09%)
Closing price 07/10/2026 03:59 PM Eastern
Extended Trading
$10.40 +0.01 (+0.10%)
As of 07/10/2026 05:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AVTR vs. A, DHR, RVTY, TMO, and VLTO

Should you buy Avantor stock or one of its competitors? MarketBeat compares Avantor with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Avantor include Agilent Technologies (A), Danaher (DHR), Revvity (RVTY), Thermo Fisher Scientific (TMO), and Veralto (VLTO).

How does Avantor compare to Agilent Technologies?

Agilent Technologies (NYSE:A) and Avantor (NYSE:AVTR) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

Agilent Technologies has a beta of 1.25, suggesting that its stock price is 25% more volatile than the broader market. Comparatively, Avantor has a beta of 0.94, suggesting that its stock price is 6% less volatile than the broader market.

Agilent Technologies has a net margin of 19.55% compared to Avantor's net margin of -8.42%. Agilent Technologies' return on equity of 24.33% beat Avantor's return on equity.

Company Net Margins Return on Equity Return on Assets
Agilent Technologies19.55% 24.33% 12.99%
Avantor -8.42%9.95%4.78%

In the previous week, Agilent Technologies had 6 more articles in the media than Avantor. MarketBeat recorded 9 mentions for Agilent Technologies and 3 mentions for Avantor. Agilent Technologies' average media sentiment score of 0.83 beat Avantor's score of 0.75 indicating that Agilent Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Agilent Technologies
4 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Avantor
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

95.1% of Avantor shares are held by institutional investors. 0.3% of Avantor shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Agilent Technologies has higher revenue and earnings than Avantor. Avantor is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agilent Technologies$6.95B5.47$1.30B$4.9827.02
Avantor$6.55B1.08-$530.20M-$0.81N/A

Agilent Technologies presently has a consensus target price of $159.35, indicating a potential upside of 18.42%. Avantor has a consensus target price of $10.63, indicating a potential upside of 2.21%. Given Agilent Technologies' stronger consensus rating and higher possible upside, equities research analysts clearly believe Agilent Technologies is more favorable than Avantor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Agilent Technologies
0 Sell rating(s)
4 Hold rating(s)
13 Buy rating(s)
2 Strong Buy rating(s)
2.89
Avantor
3 Sell rating(s)
12 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.94

Summary

Agilent Technologies beats Avantor on 15 of the 17 factors compared between the two stocks.

How does Avantor compare to Danaher?

Danaher (NYSE:DHR) and Avantor (NYSE:AVTR) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, media sentiment, earnings, profitability, analyst recommendations, valuation and risk.

In the previous week, Danaher had 11 more articles in the media than Avantor. MarketBeat recorded 14 mentions for Danaher and 3 mentions for Avantor. Danaher's average media sentiment score of 0.98 beat Avantor's score of 0.75 indicating that Danaher is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Danaher
11 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive
Avantor
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Danaher has higher revenue and earnings than Avantor. Avantor is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Danaher$24.57B5.74$3.61B$5.1738.51
Avantor$6.55B1.08-$530.20M-$0.81N/A

Danaher has a net margin of 14.89% compared to Avantor's net margin of -8.42%. Danaher's return on equity of 10.91% beat Avantor's return on equity.

Company Net Margins Return on Equity Return on Assets
Danaher14.89% 10.91% 6.94%
Avantor -8.42%9.95%4.78%

79.1% of Danaher shares are owned by institutional investors. Comparatively, 95.1% of Avantor shares are owned by institutional investors. 10.8% of Danaher shares are owned by insiders. Comparatively, 0.3% of Avantor shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Danaher has a beta of 0.79, suggesting that its stock price is 21% less volatile than the broader market. Comparatively, Avantor has a beta of 0.94, suggesting that its stock price is 6% less volatile than the broader market.

Danaher currently has a consensus price target of $231.64, suggesting a potential upside of 16.34%. Avantor has a consensus price target of $10.63, suggesting a potential upside of 2.21%. Given Danaher's stronger consensus rating and higher possible upside, equities research analysts clearly believe Danaher is more favorable than Avantor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Danaher
1 Sell rating(s)
4 Hold rating(s)
18 Buy rating(s)
1 Strong Buy rating(s)
2.79
Avantor
3 Sell rating(s)
12 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.94

Summary

Danaher beats Avantor on 15 of the 17 factors compared between the two stocks.

How does Avantor compare to Revvity?

Revvity (NYSE:RVTY) and Avantor (NYSE:AVTR) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Revvity has a net margin of 8.26% compared to Avantor's net margin of -8.42%. Avantor's return on equity of 9.95% beat Revvity's return on equity.

Company Net Margins Return on Equity Return on Assets
Revvity8.26% 8.00% 4.83%
Avantor -8.42%9.95%4.78%

86.7% of Revvity shares are held by institutional investors. Comparatively, 95.1% of Avantor shares are held by institutional investors. 0.9% of Revvity shares are held by company insiders. Comparatively, 0.3% of Avantor shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Revvity has higher earnings, but lower revenue than Avantor. Avantor is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revvity$2.86B4.39$241.20M$2.0953.79
Avantor$6.55B1.08-$530.20M-$0.81N/A

Revvity has a beta of 1.09, suggesting that its stock price is 9% more volatile than the broader market. Comparatively, Avantor has a beta of 0.94, suggesting that its stock price is 6% less volatile than the broader market.

In the previous week, Revvity had 7 more articles in the media than Avantor. MarketBeat recorded 10 mentions for Revvity and 3 mentions for Avantor. Avantor's average media sentiment score of 0.75 beat Revvity's score of -0.24 indicating that Avantor is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Revvity
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Avantor
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Revvity presently has a consensus price target of $108.92, suggesting a potential downside of 3.12%. Avantor has a consensus price target of $10.63, suggesting a potential upside of 2.21%. Given Avantor's higher probable upside, analysts clearly believe Avantor is more favorable than Revvity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Revvity
2 Sell rating(s)
10 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.13
Avantor
3 Sell rating(s)
12 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.94

Summary

Revvity beats Avantor on 11 of the 16 factors compared between the two stocks.

How does Avantor compare to Thermo Fisher Scientific?

Avantor (NYSE:AVTR) and Thermo Fisher Scientific (NYSE:TMO) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

Thermo Fisher Scientific has higher revenue and earnings than Avantor. Avantor is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avantor$6.55B1.08-$530.20M-$0.81N/A
Thermo Fisher Scientific$44.56B4.39$6.70B$18.1928.96

Thermo Fisher Scientific has a net margin of 15.15% compared to Avantor's net margin of -8.42%. Thermo Fisher Scientific's return on equity of 16.86% beat Avantor's return on equity.

Company Net Margins Return on Equity Return on Assets
Avantor-8.42% 9.95% 4.78%
Thermo Fisher Scientific 15.15%16.86%8.15%

In the previous week, Thermo Fisher Scientific had 22 more articles in the media than Avantor. MarketBeat recorded 25 mentions for Thermo Fisher Scientific and 3 mentions for Avantor. Thermo Fisher Scientific's average media sentiment score of 1.24 beat Avantor's score of 0.75 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Avantor
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Thermo Fisher Scientific
18 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
2 Very Negative mention(s)
Positive

Avantor has a beta of 0.94, meaning that its stock price is 6% less volatile than the broader market. Comparatively, Thermo Fisher Scientific has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market.

Avantor presently has a consensus price target of $10.63, indicating a potential upside of 2.21%. Thermo Fisher Scientific has a consensus price target of $602.14, indicating a potential upside of 14.32%. Given Thermo Fisher Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Thermo Fisher Scientific is more favorable than Avantor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avantor
3 Sell rating(s)
12 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.94
Thermo Fisher Scientific
0 Sell rating(s)
6 Hold rating(s)
17 Buy rating(s)
2 Strong Buy rating(s)
2.84

95.1% of Avantor shares are owned by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are owned by institutional investors. 0.3% of Avantor shares are owned by insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Thermo Fisher Scientific beats Avantor on 15 of the 17 factors compared between the two stocks.

How does Avantor compare to Veralto?

Avantor (NYSE:AVTR) and Veralto (NYSE:VLTO) are both measuring and control equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

95.1% of Avantor shares are held by institutional investors. Comparatively, 91.3% of Veralto shares are held by institutional investors. 0.3% of Avantor shares are held by insiders. Comparatively, 0.4% of Veralto shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Veralto had 5 more articles in the media than Avantor. MarketBeat recorded 8 mentions for Veralto and 3 mentions for Avantor. Veralto's average media sentiment score of 0.93 beat Avantor's score of 0.75 indicating that Veralto is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Avantor
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Veralto
3 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Veralto has lower revenue, but higher earnings than Avantor. Avantor is trading at a lower price-to-earnings ratio than Veralto, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avantor$6.55B1.08-$530.20M-$0.81N/A
Veralto$5.50B4.14$940M$3.8723.96

Veralto has a net margin of 17.33% compared to Avantor's net margin of -8.42%. Veralto's return on equity of 34.63% beat Avantor's return on equity.

Company Net Margins Return on Equity Return on Assets
Avantor-8.42% 9.95% 4.78%
Veralto 17.33%34.63%13.44%

Avantor presently has a consensus price target of $10.63, indicating a potential upside of 2.21%. Veralto has a consensus price target of $106.22, indicating a potential upside of 14.54%. Given Veralto's stronger consensus rating and higher probable upside, analysts plainly believe Veralto is more favorable than Avantor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avantor
3 Sell rating(s)
12 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.94
Veralto
0 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.45

Avantor has a beta of 0.94, indicating that its share price is 6% less volatile than the broader market. Comparatively, Veralto has a beta of 0.63, indicating that its share price is 37% less volatile than the broader market.

Summary

Veralto beats Avantor on 13 of the 16 factors compared between the two stocks.

Get Avantor News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVTR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVTR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVTR vs. The Competition

MetricAvantorMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$7.18B$9.59B$7.14B$23.42B
Dividend YieldN/A1.63%2.68%4.04%
P/E Ratio-12.8326.4127.4231.40
Price / Sales1.0818.14592.9220.42
Price / Cash6.94114.0549.3425.05
Price / Book1.276.0510.884.77
Net Income-$530.20M$179.69M$3.59B$1.07B
7 Day Performance0.98%-1.68%-0.26%-0.50%
1 Month Performance7.44%6.63%4.52%0.64%
1 Year Performance-23.57%11.95%29.17%16.94%

Avantor Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVTR
Avantor
1.7696 of 5 stars
$10.40
-1.1%
$10.63
+2.2%
-24.2%$7.18B$6.55BN/A13,500
A
Agilent Technologies
4.8904 of 5 stars
$130.78
+0.1%
$160.88
+23.0%
+8.4%$36.91B$6.95B26.2618,100
DHR
Danaher
4.6093 of 5 stars
$193.62
-2.2%
$233.52
+20.6%
-3.1%$140.09B$24.57B37.4560,000
RVTY
Revvity
2.1814 of 5 stars
$112.85
-0.8%
$108.92
-3.5%
+9.7%$12.69B$2.90B54.0011,000
TMO
Thermo Fisher Scientific
4.5407 of 5 stars
$517.76
-1.1%
$601.61
+16.2%
+22.1%$194.52B$44.56B28.46125,000

Related Companies and Tools


This page (NYSE:AVTR) was last updated on 7/11/2026 by MarketBeat.com Staff.
From Our Partners